Clinical trial · Observational
Study on AUNIP as a Novel Tumor Marker for Cervical Cancer
NCT06118463CI-TRIAL-00071210not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To detect the expression of AUNIP in cervical cancer serum, and to clarify its diagnostic and prognostic value.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Detection of serum AUNIP expression | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- study group
- description
- Women aged 20-60; There is a definite pathological diagnosis of cervical cancer
- interventionNames
- Diagnostic Test: Detection of serum AUNIP expression
- label
- Healthy control group
- description
- Women aged 20-60; No tumors in the uterus or other parts of the body; No inflammatory disease; Blood routine and blood biochemical tests are normal.
- interventionNames
- Diagnostic Test: Detection of serum AUNIP expression
Primary outcomes (1)
- measure
- AUNIP expression in serum
- timeFrame
- through study completion, an average of 3 year
- description
- Serum AUNIP expression is detected by ELISA kit. The results will be recorded seperately.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: Study group inclusion criteria: * Women aged 20-60 * There is a definite pathological diagnosis of cervical cancer Healthy control group: * Women aged 20-60 * No tumors in the uterus or other parts of the body * No inflammatory disease * Blood routine and blood biochemical tests are normal Exclusion Criteria: Exclusion criteria of the study group: * There are other lesions in the uterus and uterine adnexa Exclusion criteria of healthy control group: * Pregnant, lactating or menarche women * Women who are undergoing human papillomavirus (HPV) vaccination
References
Publications (2)
- BACKGROUNDYang Z, Liang X, Fu Y, Liu Y, Zheng L, Liu F, Li T, Yin X, Qiao X, Xu X. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma. EBioMedicine. 2019 Sep;47:44-57. doi: 10.1016/j.ebiom.2019.08.013. Epub 2019 Aug 10. PMID 31409573
- BACKGROUNDMa C, Kang W, Yu L, Yang Z, Ding T. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Front Oncol. 2020 Dec 9;10:590006. doi: 10.3389/fonc.2020.590006. eCollection 2020. PMID 33363020